Suppr超能文献

尿激酶受体上玻连蛋白结合位点的定位:由结构域I和侧翼结构域间连接区的残基组成的连贯受体界面的参与。

Mapping of the vitronectin-binding site on the urokinase receptor: involvement of a coherent receptor interface consisting of residues from both domain I and the flanking interdomain linker region.

作者信息

Gårdsvoll Henrik, Ploug Michael

机构信息

Finsen Laboratory, Rigshospitalet, Copenhagen Biocenter, DK-2200 Copenhagen N, Denmark.

出版信息

J Biol Chem. 2007 May 4;282(18):13561-72. doi: 10.1074/jbc.M610184200. Epub 2007 Mar 13.

Abstract

The urokinase-type plasminogen activator receptor (uPAR) has been implicated as a modulator of several biochemical processes that are active during tumor invasion and metastasis, e.g. extracellular proteolysis, cell adhesion, and cell motility. The structural basis for the high affinity interaction between the urokinase-type plasminogen activator (uPA) and uPAR, which focuses cell surface-associated plasminogen activation in vivo, is now thoroughly characterized by site-directed mutagenesis studies and x-ray crystallography. In contrast, the structural basis for the interaction between uPAR and the extracellular matrix protein vitronectin, which is involved in the regulation of cell adhesion and motility, remains to be clarified. In this study, we have identified the functional epitope on uPAR that is responsible for its interaction with the full-length, extended form of vitronectin by using a comprehensive alanine-scanning library of purified single-site uPAR mutants (244 positions tested). Interestingly, the five residues identified as "hot spots" for vitronectin binding form a contiguous epitope consisting of two exposed loops connecting the central fourstranded beta-sheet in uPAR domain I (Trp(32), Arg(58), and Ile(63)) as well as a proximal region of the flexible linker peptide connecting uPAR domains I and II (Arg(91) and Tyr(92)). This binding topology provides the molecular basis for the observation that uPAR can form a ternary complex with uPA and vitronectin. Furthermore, it raises the intriguing possibility that the canonical receptor and inhibitor for uPA (uPAR and PAI-1) may have reached a convergent solution for binding to the somatomedin B domain of vitronectin.

摘要

尿激酶型纤溶酶原激活物受体(uPAR)被认为是肿瘤侵袭和转移过程中多种活跃生化过程的调节因子,例如细胞外蛋白水解、细胞黏附和细胞运动。尿激酶型纤溶酶原激活物(uPA)与uPAR之间的高亲和力相互作用是体内细胞表面相关纤溶酶原激活的关键,目前通过定点诱变研究和X射线晶体学已对其结构基础进行了全面表征。相比之下,uPAR与细胞外基质蛋白玻连蛋白之间相互作用的结构基础仍有待阐明,玻连蛋白参与细胞黏附和运动的调节。在本研究中,我们利用纯化的单一位点uPAR突变体的综合丙氨酸扫描文库(测试了244个位点),确定了uPAR上负责其与全长、延伸形式玻连蛋白相互作用的功能表位。有趣的是,被确定为玻连蛋白结合“热点”的五个残基形成了一个连续表位,由连接uPAR结构域I中中央四链β-折叠的两个暴露环(Trp(32)、Arg(58)和Ile(63))以及连接uPAR结构域I和II的柔性连接肽的近端区域(Arg(91)和Tyr(92))组成。这种结合拓扑结构为uPAR可与uPA和玻连蛋白形成三元复合物这一观察结果提供了分子基础。此外,它还引发了一个有趣的可能性,即uPA的经典受体和抑制剂(uPAR和PAI-1)可能在与玻连蛋白的生长调节素B结构域结合方面达成了趋同解决方案。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验